CRP and rheumatoid arthritis: The baseline characteristics of RA in our study, including the duration of conventional DMARD therapy before initiation of biologic therapy, VAS pain scores, duration of morning stiffness, and CRP levels, were similar to those reported in the AMBITION study in 2010 and the ADACTA study in 2013 [19,20].